Regular Home Use of Dual-light Photodynamic Therapy on Oral Health in Adolescents Undergoing Fixed Orthodontic Treatment

Sponsor
Koite Health Oy (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT05825742
Collaborator
University of Helsinki (Other), Helsinki University Central Hospital (Other)
40
1
2
41
1

Study Details

Study Description

Brief Summary

This study is designed to determine the efficacy of the Lumoral method on oral health in adolescents undergoing fixed orthodontic treatment. Improved supragingival plaque control can help to also sustain the subgingival plaque management in the long term. In addition, the device might have a photobiomodulation effect on periodontal tissues.

Condition or Disease Intervention/Treatment Phase
  • Device: Lumoral Treatment
  • Other: Standard oral health instructions
N/A

Detailed Description

Orthodontic treatment is one of the most common dental treatments in children and adolescents. The use of fixed orthodontic appliances makes it difficult for the patients to keep their oral hygiene to an optimum level of cleanliness. Poor oral hygiene attracts significant plaque accumulation around the fixed orthodontic treatment appliances, and subsequent white spot lesions can occur rapidly, usually on the cervical and middle third of the buccal surfaces of bracketed teeth. Patients with the fixed orthodontic treatment appliances have an increased risk of caries and gingivitis.

The Lumoral is a CE-marked medical device developed to provide a potent, targeted antibacterial action on dental plaque in a home environment. The device mechanism of action is antibacterial photodynamic therapy (aPDT). The device is used by swishing a mouth rinse, which has a strong adherence to dental plaque. The plaque-adhered photoactive mouth rinse can be activated by a simple to use light applicator. Preliminary results have shown a promising anti-inflammatory response in addition to plaque reduction.

Forty (40) subjects undergoing fixed orthodontic treatment are randomized to the Lumoral treatment group or the control group. All subjects shall receive polishing and oral hygiene instruction. All patients shall be assessed for the clinical measurements including visible plaque index (VPI), bleeding on probing (BOP), and orthodontic plaque index (OPI) at baseline and at 4 weeks and 12 weeks after baseline. In addition, microbiological analyses shall be performed at baseline and at 12 weeks after baseline.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants in two groups (Study group and Control group) shall receive instructions for standard oral hygiene. The same assessments are done for participants in both groups, and within the same time periods. The Study group will also be using the Lumoral Treatment device.Participants in two groups (Study group and Control group) shall receive instructions for standard oral hygiene. The same assessments are done for participants in both groups, and within the same time periods. The Study group will also be using the Lumoral Treatment device.
Masking:
None (Open Label)
Masking Description:
The participants, care providers, and investigators shall be masked before the first measurements. The randomization will be conducted after the first measurements.
Primary Purpose:
Treatment
Official Title:
Efficacy of Regular Home Use of Dual-light Photodynamic Therapy on Oral Health in Adolescents Undergoing Fixed Orthodontic Treatment - Randomized, Controlled Clinical Study
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Oct 1, 2024
Anticipated Study Completion Date :
Dec 31, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Lumoral Treatment (Study group)

Subjects will receive detailed instructions for the use of Lumoral treatment -device. Subjects will be instructed to use the Lumoral treatment -device and follow the protocol once a day for two months and to keep a diary. Subjects will receive the latest standard oral hygiene instructions according to the Swedish dental association's guidelines.

Device: Lumoral Treatment
Subjects will receive detailed instructions for the use of Lumoral treatment -device. Subjects will be instructed to use the Lumoral treatment -device and follow the protocol once a day for two months and to keep a diary.

Other: Standard oral health instructions
Subjects will receive the latest standard oral hygiene instructions according to the Swedish dental association's guidelines.

Other: Standard of care (Control group)

Subjects will receive the latest standard oral hygiene instructions according to the Swedish dental association's guidelines.

Other: Standard oral health instructions
Subjects will receive the latest standard oral hygiene instructions according to the Swedish dental association's guidelines.

Outcome Measures

Primary Outcome Measures

  1. Change in Visible plaque index (VPI) [12 weeks]

    A full-mouth assessment, measured at six sites per tooth. Dichotomous scoring to each site of the tooth as plaque "1 present" and "0 absent" VPI is reported as the percentage (%) of sites with plaque. Calculation formula: number of sites with plaque/ 6 times number of teeth

Secondary Outcome Measures

  1. Change in Bleeding on probing (BOP) [12 weeks]

    A full-mouth assessment at six sites per tooth (mesiobuccal, buccal, distobuccal, mesiolingual, lingual, distolingual) Gingival bleeding is considered as positive if bleeding occurs within 15 seconds after gentle probing with a probe at the sulcus. Dichotomous scoring to each site of the tooth as bleeding "1 present" and "0 absent" BOP is reported as the percentage (%) of sites with positive findings. Calculation formula: number of bleeding sites/ 6 times number of teeth

  2. Change in Orthodontic plaque index (OPI) [12 weeks]

    The OPI indicates the presence of plaque around the multibracket appliance after staining the teeth with a plaque-disclosing solution. Using the data from the digital photographs, selected six (6) index teeth that bear an adhesively bonded bracket will be evaluated. The status is indicated as a score from 0 to 4. The degree of plaque accumulation on each aspect of the bracket base and the condition of the adjacent marginal gingivae are assessed: 0 = No plaque deposits on the tooth surfaces surrounding the bracket base = Plaque deposits on one tooth surface at the bracket base = Plaque deposits on two tooth surfaces at the bracket base = Plaque deposits on three tooth surfaces at the bracket base = Plaque deposits on four tooth surfaces at the bracket base and/or gingival inflammation indicators (plaque deposits near the gingiva do not necessarily have to be present)

  3. Change in periodontal microbiological flora [12 weeks]

    Microbiological sampling and analysis: Quantification of periodontopathic bacteria by 16S rRNA sequencing analysis. Microbiological samples can be collected using Iso Taper Paper Points, size-20 (VDW GmbH) from the plaque on the surface of the teeth, using a curette if needed. The paper points can be placed into sterile, small-aliquot containers, and immediately stored at -20°C until analysis. 16S rRNA sequencing can be performed at a qualified laboratory assigned by the study sponsor

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age of 15-18 years old

  • starting fixed orthodontic treatment

  • good oral hygiene according to the dentist's assessment

  • absence of periodontal disease and lack of oral lesion

  • signed a written consent form, including information to caregivers.

Exclusion Criteria:
  • any chronic diseases

  • medications that could influence the study (according to the dentists' assessment)

  • active caries or a supposed high risk of caries

  • gingivitis (bleeding on probing >10%)

  • use of antiseptic mouthwashes

  • smoking

  • use of antibiotics or anti-inflammatory therapy within 3 months before entering the study or during the study

  • unable to cooperate with the protocol.

  • pregnancy or lactation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Borgska Villans Specialisttandvård Lund Sweden 22355

Sponsors and Collaborators

  • Koite Health Oy
  • University of Helsinki
  • Helsinki University Central Hospital

Investigators

  • Principal Investigator: Ann-Marie Roos Jansåker, Professor, Borgska Villans Specialisttandvård
  • Study Director: Tommi Pätilä, Docent, Koite Health

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Koite Health Oy
ClinicalTrials.gov Identifier:
NCT05825742
Other Study ID Numbers:
  • CLEAN-BRACKET
First Posted:
Apr 24, 2023
Last Update Posted:
Apr 24, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 24, 2023